IRIS Accounts Production v25.1.0.734 09305354 Board of Directors 29.6.23 28.6.24 28.6.24 false true false false false true false Ordinary A 0.01 Ordinary B 0.01 0.01 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh093053542023-06-28093053542024-06-28093053542023-06-292024-06-28093053542022-06-28093053542022-06-292023-06-28093053542023-06-2809305354ns15:EnglandWales2023-06-292024-06-2809305354ns14:PoundSterling2023-06-292024-06-2809305354ns10:Director12023-06-292024-06-2809305354ns10:PrivateLimitedCompanyLtd2023-06-292024-06-2809305354ns10:SmallEntities2023-06-292024-06-2809305354ns10:AuditExempt-NoAccountantsReport2023-06-292024-06-2809305354ns10:SmallCompaniesRegimeForDirectorsReport2023-06-292024-06-2809305354ns10:SmallCompaniesRegimeForAccounts2023-06-292024-06-2809305354ns10:FullAccounts2023-06-292024-06-280930535412023-06-292024-06-2809305354ns10:OrdinaryShareClass12023-06-292024-06-2809305354ns10:OrdinaryShareClass22023-06-292024-06-280930535411ns10:OrdinaryShareClass12023-06-292024-06-2809305354ns10:Director22023-06-292024-06-2809305354ns10:Director32023-06-292024-06-2809305354ns10:RegisteredOffice2023-06-292024-06-2809305354ns5:CurrentFinancialInstruments2024-06-2809305354ns5:CurrentFinancialInstruments2023-06-2809305354ns5:Non-currentFinancialInstruments2024-06-2809305354ns5:Non-currentFinancialInstruments2023-06-2809305354ns5:ShareCapital2024-06-2809305354ns5:ShareCapital2023-06-2809305354ns5:SharePremium2024-06-2809305354ns5:SharePremium2023-06-2809305354ns5:RetainedEarningsAccumulatedLosses2024-06-2809305354ns5:RetainedEarningsAccumulatedLosses2023-06-2809305354ns5:FurnitureFittings2023-06-292024-06-2809305354ns5:IntangibleAssetsOtherThanGoodwill2023-06-2809305354ns5:IntangibleAssetsOtherThanGoodwill2023-06-292024-06-2809305354ns5:IntangibleAssetsOtherThanGoodwill2024-06-2809305354ns5:IntangibleAssetsOtherThanGoodwill2023-06-2809305354ns5:FurnitureFittings2023-06-2809305354ns5:FurnitureFittings2024-06-2809305354ns5:FurnitureFittings2023-06-2809305354ns5:WithinOneYearns5:CurrentFinancialInstruments2024-06-2809305354ns5:WithinOneYearns5:CurrentFinancialInstruments2023-06-2809305354ns5:DeferredTaxation2023-06-2809305354ns5:DeferredTaxation2023-06-292024-06-2809305354ns5:DeferredTaxation2024-06-2809305354ns10:OrdinaryShareClass12024-06-2809305354ns10:OrdinaryShareClass22024-06-28
REGISTERED NUMBER: 09305354 (England and Wales)










UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 28 JUNE 2024

FOR

BDM MEDICAL LIMITED
TRADING AS
DOCTALY

BDM MEDICAL LIMITED (REGISTERED NUMBER: 09305354)
TRADING AS DOCTALY






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 JUNE 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


BDM MEDICAL LIMITED
TRADING AS DOCTALY

COMPANY INFORMATION
FOR THE YEAR ENDED 28 JUNE 2024







DIRECTORS: Mr P J Tyler
Dr P Velayuthan





REGISTERED OFFICE: Unit 2.02 High Weald House
Glovers End
Bexhill
East Sussex
TN39 5ES





REGISTERED NUMBER: 09305354 (England and Wales)





ACCOUNTANTS: Acuity Professional Partnership LLP
Unit 2.02 High Weald House
Glovers End, Bexhill,
East Sussex,
United Kingdom
TN39 5ES

BDM MEDICAL LIMITED (REGISTERED NUMBER: 09305354)
TRADING AS DOCTALY

STATEMENT OF FINANCIAL POSITION
28 JUNE 2024

2024 2023
Notes £    £    £   
FIXED ASSETS
Intangible assets 4 708,455 864,537
Tangible assets 5 4,294 5,725
712,749 870,262

CURRENT ASSETS
Debtors 6 364,612 268,824
Cash at bank 32,601 46,097
397,213 314,921
CREDITORS
Amounts falling due within one year 7 46,796 18,664
NET CURRENT ASSETS 350,417 296,257
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,063,166

1,166,519

CREDITORS
Amounts falling due after more than one
year

8

24,002

98,705
NET ASSETS 1,039,164 1,067,814

CAPITAL AND RESERVES
Called up share capital 10 1,538 135
Share premium 1,602,687 1,382,858
Retained earnings (565,061 ) (315,179 )
SHAREHOLDERS' FUNDS 1,039,164 1,067,814

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 June 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

BDM MEDICAL LIMITED (REGISTERED NUMBER: 09305354)
TRADING AS DOCTALY

STATEMENT OF FINANCIAL POSITION - continued
28 JUNE 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20 May 2025 and were signed on its behalf by:





Mr B M Teichman - Director


BDM MEDICAL LIMITED (REGISTERED NUMBER: 09305354)
TRADING AS DOCTALY

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 JUNE 2024

1. STATUTORY INFORMATION

BDM Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is Sterling (£), rounded to the nearest whole Pound.

2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The preparation of financial statements in conformity with FRS 102 section 1A requires the use of certain critical accounting estimates. lt also requires management to exercise judgement in applying the company's accounting policies.

ACCOUNTING ESTIMATES AND JUDGEMENTS
In preparing the financial statements, the directors are required to make estimates and judgements about the carrying amounts of assets and liabilities. The estimates and assumptions are reviewed on an ongoing basis and are based on historical experience and other factors that are considered by the directors to be relevant. Revision to accounting estimates are recognised in the period in which the estimate is revised.

TURNOVER
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible fixed assets
Intangible Fixed Assets consists of software and development costs capitalised. Amortisation is provided at rates calculated to write off the cost of Intangible assets, less their estimated residual value, over their expected useful lives of 5 years on straight line basis.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


BDM MEDICAL LIMITED (REGISTERED NUMBER: 09305354)
TRADING AS DOCTALY

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 JUNE 2024

2. ACCOUNTING POLICIES - continued
DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

BDM MEDICAL LIMITED (REGISTERED NUMBER: 09305354)
TRADING AS DOCTALY

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 JUNE 2024

2. ACCOUNTING POLICIES - continued

FINANCIAL INSTRUMENTS
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset , with the net amounts presented in the financial statements , when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

BASIC FINANCIAL ASSETS
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

CLASSIFICATION OF FINANCIAL LIABILITIES
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

BASIC FINANCIAL LIABILITIES
Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payment ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

GOVERNMENT GRANT
Grants receivable under the government's Job Retention Scheme are recognised as other operating income within the profit and loss account when there is reasonable assurance that the entity will comply with the conditions attached to the grant and that the grant income will be received. Grant income relating to the Job Retention Scheme will be recognised in the period to which the underlying furloughed staff costs relate to and when the payroll liability has been incurred by the company. The income is taxable and amounts not received by the reporting date are included in other debtors.

GOING CONCERN
The accounts have been prepared under the going concern basis, as the directors of the company has agreed to provide the company with continued funding, to enable it to meet its liabilities as they fall due.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 4 ) .

BDM MEDICAL LIMITED (REGISTERED NUMBER: 09305354)
TRADING AS DOCTALY

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 JUNE 2024

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 29 June 2023 1,642,542
Additions 109,609
At 28 June 2024 1,752,151
AMORTISATION
At 29 June 2023 778,005
Charge for year 265,691
At 28 June 2024 1,043,696
NET BOOK VALUE
At 28 June 2024 708,455
At 28 June 2023 864,537

5. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 29 June 2023
and 28 June 2024 20,168
DEPRECIATION
At 29 June 2023 14,443
Charge for year 1,431
At 28 June 2024 15,874
NET BOOK VALUE
At 28 June 2024 4,294
At 28 June 2023 5,725

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 64,779 -
Other debtors 99 99
Deferred tax asset 299,734 268,725
364,612 268,824

BDM MEDICAL LIMITED (REGISTERED NUMBER: 09305354)
TRADING AS DOCTALY

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 JUNE 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 10,000 10,000
Taxation and social security 26,462 3,782
Other creditors 10,334 4,882
46,796 18,664

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans 24,002 25,619
Other creditors - 73,086
24,002 98,705

9. DEFERRED TAX
£   
Balance at 29 June 2023 (268,725 )
Provided during year (31,009 )
Balance at 28 June 2024 (299,734 )

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
153,089,009 Ordinary A £0.00001 1,531 128
742,500 Ordinary B £0.00001 7 7
1,538 135

140,764,861 Ordinary A shares of £0.00001 each were allotted as fully paid at a premium of 0.001551667 per share during the year.

11. CONTROLLING PARTY

The company is controlled by the directors.